Pharmastem Therapeutics, Inc.
Records under this name other than patents Pharmastem Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Pharmastem Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,605,275 | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood Lapsed on the fee record Ended Aug 12, 2011 · USPTO record | Lapsed on the fee record | Ended Aug 12, 2011 | USPTO record |
| US 6,569,427 | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood Lapsed on the fee record Ended May 27, 2011 · USPTO record | Lapsed on the fee record | Ended May 27, 2011 | USPTO record |
| US 6,461,645 | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood Lapsed on the fee record Ended Oct 8, 2010 · USPTO record | Lapsed on the fee record | Ended Oct 8, 2010 | USPTO record |
| US 5,004,681 | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood Term ended Term ended no later than Apr 2, 2011 · Low confidence | Term ended | Term ended no later than Apr 2, 2011 | Low confidence |
| US 5,192,553 | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use Term ended Term ended no later than Mar 9, 2013 · Low confidence | Term ended | Term ended no later than Mar 9, 2013 | Low confidence |